Pharmaceutical

The blood purification technology is used for the treatment of severe treatment-refectory systematic lupus erythematosus (SLE).Stock.adobe.com Santersus AG announced FDA has granted Breakthrough Device Designation to its NucleoCapture blood purification technology for the treatment of SLE. This is now the second Breakthrough Device designation granted to NucleoCapture as it was recognized previously for the treatment…

Shanghai.China-Jan. 8th 2022: Fosun Pharma company logo on office building at night. A Chinese pharmaceutical company mostly owned by Fosun International | Image Credit: © Robert – stock.adobe.com Shanghai-based Fosun Pharma has reached an agreement with Accro Bioscience to exclusively develop, manufacture and commercialize Accro’s highly selective tyrosine kinase 2 (TYK2)/Janus kinase 1 (JAK1) inhibitor…

Image Credit: Adobe Stock Images/KKStock.com With an increase in price forthcoming, Eli Lilly has decided to temporarily pause UK shipments of Mounjaro1—the company’s branded form of tirzepatide that is approved for the treatment of type 2 diabetes in adults—until Sept. 1. This signifies that pharmacies will not be able to restock the medication until Sept….

Image Credit: Adobe Stock Images/KKStock.com With an increase in price forthcoming, Eli Lilly has decided to temporarily pause UK shipments of Mounjaro1—the company’s branded form of tirzepatide that is approved for the treatment of type 2 diabetes in adults—until Sept. 1. This signifies that pharmacies will not be able to restock the medication until Sept….

Pharmaceutical Commerce presents The Most Favored Nation Mandate webinar! Earlier this year, Donald Trump issued an executive order stating that pharma companies must treat the United States as a most-favored-nation (MFN). Essentially, the order states that drug prices in the US should at least match the lowest price across the international markets. This summer, the…

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur – © Artur – stock.adobe.com FDA announced on Aug. 27, 2025 that Unichem Pharmaceuticals (USA) has voluntarily recalled one lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg. The recall was initiated because…

In this first installment of a new PharmTech feature, we’ll highlight the week’s industry news in an easy-to-consume, fun format. New roundups will drop every Friday, so be sure to come back each week. And be sure to check the links below for more in-depth coverage of each story. Our news stories from this week…

Doctor Harshit Jain, founder and global CEO of Doceree, spoke with Pharmaceutical Executive about leveraging point-of-care marketing momentum and its influence on decision making and how Doceree maintains contextual relevance in marketing on a national scale. Pharmaceutical Executive: How is Doceree leveraging Point-of-care Marketing momentum to influence its decisions?Dr. Harshit Jain: Point of care is…

Generics specialist Teva Pharmaceuticals has received FDA approval for Saxenda. Image credit: Mohammed_AI_Ali via Shutterstock.com. Generics company Teva Pharmaceutical has obtained approval from the US Food and Drug Administration (FDA) for its generic referencing Novo Nordisk’s previous generation of injectable weight loss drug, Saxenda (liraglutide). This marks the first time a generic glucagon-like peptide-1 receptor…

FDA issued the CRL to the BLA resubmission indicating that FDA cannot approve Lytenava in its present form.Stock.adobe.com Outlook Therapeutics announced that FDA has issued a complete response letter (CRL) to its biologics license application (BLA) resubmission, suggesting that Lytenava cannot be approved in its current form for treatment of wet age-related macular degeneration (wet…